XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Total
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2023   427 856,182      
Beginning balance at Dec. 31, 2023 $ 6,109,654 $ 4 $ 77,078 $ 153,192,228 $ (146,976,855) $ (182,801)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-Based Compensation 496,413     496,413    
Issuance of Common Stock and Warrants from Private Placement, Net of Offering Costs (in shares)     1,755,556      
Issuance of Common Stock and Warrants from Private Placement, Net of Offering Costs 13,808,816   $ 158,000 13,650,816    
Issuance of Common Stock from Warrant Exercises (in shares)     358,831      
Issuance of Common Stock from Warrant Exercises 1,689,339   $ 32,295 1,657,044    
Issuance of Common Stock from Restricted Stock Awards (in shares)     30,604      
Issuance of Common Stock from Restricted Stock Awards 0   $ 306 (306)    
Adjustments Due to the Rounding Impact from the Reverse Stock Split for Fractional Shares (in shares)     (385)      
Unrealized Gain (Loss) on Investments 73,607         73,607
Foreign Currency Translation Adjustment 33,988         33,988
Net Income (Loss) 7,818,235       7,818,235  
Ending balance (in shares) at Sep. 30, 2024   427 3,000,788      
Ending balance at Sep. 30, 2024 30,030,052 $ 4 $ 267,679 168,996,195 (139,158,620) (75,206)
Beginning balance (in shares) at Jun. 30, 2024   427 2,970,545      
Beginning balance at Jun. 30, 2024 33,101,673 $ 4 $ 267,373 168,825,325 (135,745,294) (245,735)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-Based Compensation 171,176     171,176    
Issuance of Common Stock from Restricted Stock Awards (in shares)     30,604      
Issuance of Common Stock from Restricted Stock Awards 0   $ 306 (306)    
Adjustments Due to the Rounding Impact from the Reverse Stock Split for Fractional Shares (in shares)     (361)      
Unrealized Gain (Loss) on Investments 76,435         76,435
Foreign Currency Translation Adjustment 94,094         94,094
Net Income (Loss) (3,413,326)       (3,413,326)  
Ending balance (in shares) at Sep. 30, 2024   427 3,000,788      
Ending balance at Sep. 30, 2024 30,030,052 $ 4 $ 267,679 168,996,195 (139,158,620) (75,206)
Beginning balance (in shares) at Dec. 31, 2024   427 3,000,788      
Beginning balance at Dec. 31, 2024 25,759,776 $ 4 $ 267,679 169,156,374 (143,382,122) (282,159)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-Based Compensation 665,788     665,788    
Issuance of Common Stock from Warrant Exercises (in shares)     389,634      
Issuance of Common Stock from Warrant Exercises 265,360   $ 3,896 261,464    
Issuance of Common Stock from Restricted Stock Awards (in shares)     43,069      
Issuance of Common Stock from Restricted Stock Awards 0   $ 431 (431)    
Unrealized Gain (Loss) on Investments (16,001)         (16,001)
Foreign Currency Translation Adjustment 54,451         54,451
Net Income (Loss) (4,318,633)       (4,318,633)  
Ending balance (in shares) at Sep. 30, 2025   427 3,433,491      
Ending balance at Sep. 30, 2025 22,410,742 $ 4 $ 272,006 170,083,195 (147,700,755) (243,708)
Beginning balance (in shares) at Jun. 30, 2025   427 3,433,491      
Beginning balance at Jun. 30, 2025 22,127,478 $ 4 $ 272,006 169,828,797 (147,727,560) (245,769)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-Based Compensation 254,398     254,398    
Unrealized Gain (Loss) on Investments 11,214         11,214
Foreign Currency Translation Adjustment (9,153)         (9,153)
Net Income (Loss) 26,806       26,806  
Ending balance (in shares) at Sep. 30, 2025   427 3,433,491      
Ending balance at Sep. 30, 2025 $ 22,410,742 $ 4 $ 272,006 $ 170,083,195 $ (147,700,755) $ (243,708)